OverviewChartNewsTraderScreen

BVT Knock-Out PGR/  DE000VD3CRC9  /

Frankfurt Zert./VONT
28/05/2024  13:57:19 Chg.-0.030 Bid14:50:44 Ask14:50:44 Underlying Strike price Expiration date Option type
5.390EUR -0.55% 5.400
Bid Size: 7,000		 5.480
Ask Size: 7,000		 Progressive Corporat... 262.68 - 31/12/2078 Put
GlobeNewswire 14:00 Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire 13:30 Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire 13:30 TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire 13:10 Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
GlobeNewswire 13:02 Golar LNG Limited Interim results for the period ended March 31 2024
GlobeNewswire 12:00 MediciNova Announces Two Poster Presentations at the 92nd EAS Congress 2024, the Annual Meeting of t...
GlobeNewswire 25/05 Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...
GlobeNewswire 24/05 Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Act...
GlobeNewswire 24/05 BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
GlobeNewswire 23/05 Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...
GlobeNewswire 21/05 Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...
GlobeNewswire 20/05 Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
TeleTrader 20/05 Yellen says US against tax on billionaires
GlobeNewswire 20/05 APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...
GlobeNewswire 20/05 Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Tria...
GlobeNewswire 20/05 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...
GlobeNewswire 16/05 BMW unveils The BMW XM Mystique Allure, a one-of-a-kind luxury vehicle inspired by the iconic superm...
GlobeNewswire 15/05 Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III P...
TeleTrader 15/05 Slovakian opposition denies connection to Fico's attack
GlobeNewswire 15/05 Progressive Reports April 2024 Results
GlobeNewswire 14/05 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...
GlobeNewswire 13/05 Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire 13/05 BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire 13/05 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire 09/05 Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...